OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present at four events in June. The company’s agenda includes a number of high-profile scientific and investment conferences, coming on the heels of their presentation of new clinical data at the 2014 ASCO Annual Meeting. OncoSec’s June meeting itinerary is as follows:
Help employers find you! Check out all the jobs and post your resume.
